3Daughters
Overview
3Daughters is a clinical development company dedicated to advancing healthcare solutions specifically tailored for women, focusing on innovative contraceptive technologies. Founded in 2021 by Mary Beth Cicero and Shelley Amster, the company is headquartered in Mansfield, Massachusetts. 3Daughters has raised a total of approximately $21.8 million through several funding rounds and is known for its distinctive product, a frameless, magnetic, non-hormonal intrauterine device (IUD) aimed at reducing the discomfort associated with traditional IUDs.
Recent Developments
- February 11, 2025: 3Daughters announced John Poulos, a former executive from AbbVie, joined their Board of Directors. His appointment is seen as a strategic move to strengthen the company’s mission to improve women’s contraceptive options.
- January 2025: The NIH announced support for the preclinical trials of 3Daughters' IUD, facilitating the evaluation of its copper release characteristics and potential benefits over traditional T-shaped devices.
- September 2024: 3Daughters secured $4.7 million in an oversubscribed seed funding round, supported by investors including UMass Amherst and Argosy Foundation. The funds are earmarked for Phase 1 clinical trials and further development of their IUD technology.
- July 2024: The company announced the closing of a $15 million Series A funding round, which will support the advancement of their clinical trials aimed at revolutionizing IUD performance.
- 2024: The firm announced a successful completion of its seed round, emphasizing the increasing market need for innovative contraception methods.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2021 |
| Headquarters | Mansfield, MA, USA |
| Founders | Mary Beth Cicero, Shelley Amster |
| Revenue | Not publicly disclosed |
| Profits | Not publicly available |
| Key Investors | Thairm Bio, UMass Amherst, Argosy Foundation, Wexford Science & Technology |
| Industry | Therapeutic Devices |
| Number of Employees | 10 |
Early History
3Daughters was founded in 2021 with a focus on creating advancements in women’s health, specifically in the realm of contraception. The founders, Mary Beth Cicero and Shelley Amster, both veterans in the healthcare industry, identified significant gaps in the available contraceptive technologies. They introduced a groundbreaking product line based on their patented IUD system, targeting the major challenges women face with existing solutions. Using a unique technology that incorporates physics and geometry, their initial product set out to address and significantly reduce the pain experienced during IUD insertion, a common deterrent for many women considering this form of contraception.
Company Profile and Achievements
3Daughters positions itself at the intersection of healthcare and technology, pioneering a new wave of contraceptive solutions. Their primary product, the 3D-001 IUD, features a frameless design that intends to alleviate the common discomforts associated with traditional T-shaped IUDs. Significant Achievements:
- Patented Technology: Their patented Slider™ system simplifies the insertion and removal process, addressing major pain points and improving the user experience.
- Clinical Trials: The company’s approach has gained significant interest, leading to support from the NIH and other investors to facilitate clinical trials aimed at mainstream adoption.
- Industry Impact: By challenging long-standing designs, 3Daughters aims to reshape the contraceptive landscape with their user-centric design approach.
Current Operations and Market Position
Currently, 3Daughters is focusing on expanding its clinical trials while securing additional funding to support this growth. The company is poised at a critical juncture where successful trials could facilitate larger market penetration. They are tapping into the growing demand for non-hormonal and less invasive contraceptive options, setting a standard for innovation in the